138 related articles for article (PubMed ID: 17669007)
1. Functionality of the immune system in patients with chronic hepatitis C: trial by superinfections and vaccinations.
Isaguliants MG
Expert Rev Vaccines; 2007 Aug; 6(4):527-37. PubMed ID: 17669007
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles.
Pham TN; Mercer SE; Michalak TI
J Viral Hepat; 2009 Aug; 16(8):547-56. PubMed ID: 19215578
[TBL] [Abstract][Full Text] [Related]
3. [Immunization guidelines regarding patients with a chronic disease].
Aubert C; Vaudaux B; Bart PA;
Rev Med Suisse; 2010 Apr; 6(245):798-803. PubMed ID: 20469661
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities?
Hernandez B; Hasson NK; Cheung R
Am J Gastroenterol; 2009 Aug; 104(8):1961-7. PubMed ID: 19491840
[TBL] [Abstract][Full Text] [Related]
5. Booster vaccinations: can immunologic memory outpace disease pathogenesis?
Pichichero ME
Pediatrics; 2009 Dec; 124(6):1633-41. PubMed ID: 19933727
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
Bode JG; Brenndörfer ED; Häussinger D
Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
8. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
Hiroishi K; Ito T; Imawari M
J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target.
Sällberg M; Frelin L; Weiland O
Expert Opin Biol Ther; 2009 Jul; 9(7):805-15. PubMed ID: 19527105
[TBL] [Abstract][Full Text] [Related]
10. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
11. Pretransplantation CD56(+) innate lymphocyte populations associated with severity of hepatitis C virus recurrence.
Rosen HR; Doherty DG; Madrigal-Estebas L; O'Farrelly C; Golden-Mason L
Liver Transpl; 2008 Jan; 14(1):31-40. PubMed ID: 18161829
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
Klade CS; Wedemeyer H; Berg T; Hinrichsen H; Cholewinska G; Zeuzem S; Blum H; Buschle M; Jelovcan S; Buerger V; Tauber E; Frisch J; Manns MP
Gastroenterology; 2008 May; 134(5):1385-95. PubMed ID: 18471515
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients.
Evison J; Farese S; Seitz M; Uehlinger DE; Furrer H; Mühlemann K
Clin Infect Dis; 2009 May; 48(10):1402-12. PubMed ID: 19361304
[TBL] [Abstract][Full Text] [Related]
14. Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection.
Jeong HY; Lee YJ; Seo SK; Lee SW; Park SJ; Lee JN; Sohn HS; Yao S; Chen L; Choi I
J Leukoc Biol; 2008 Mar; 83(3):755-64. PubMed ID: 18086898
[TBL] [Abstract][Full Text] [Related]
15. Generating memory with vaccination.
Castellino F; Galli G; Del Giudice G; Rappuoli R
Eur J Immunol; 2009 Aug; 39(8):2100-5. PubMed ID: 19637203
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis C in the advanced adult and elderly subjects.
Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
[TBL] [Abstract][Full Text] [Related]
17. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses.
Inchauspé G; Michel ML
J Viral Hepat; 2007 Nov; 14 Suppl 1():97-103. PubMed ID: 17958650
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis vaccination in patients with hepatitis C: practice and validation of codes at a large Veterans Administration Medical Centre.
Hachem CY; Kramer JR; Kanwal F; El-Serag HB
Aliment Pharmacol Ther; 2008 Nov; 28(9):1078-87. PubMed ID: 18691350
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.
Roggendorf M; Schulte I; Xu Y; Lu M
J Viral Hepat; 2007 Nov; 14 Suppl 1():51-7. PubMed ID: 17958643
[TBL] [Abstract][Full Text] [Related]
20. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.
Price GE; Soboleski MR; Lo CY; Misplon JA; Pappas C; Houser KV; Tumpey TM; Epstein SL
Vaccine; 2009 Nov; 27(47):6512-21. PubMed ID: 19729082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
